AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25773936
Drug: Intravenous contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous contrast enhanced-CT (CE-CT)
Trial: 19300235
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of trimethoprim‐sulfamethoxazole at urinary catheter removal
Trial: 12037783
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone 1,000 mg for three consecutive days
Trial: 29952137
Drug: Combined external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined external resistance (2-20 cmH2 O/L/sec)
Trial: 3095698
Drug: Amantadine 100
RxNorm normalized name: amantadine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 100 mg/day (Al)
Trial: 31089818
Drug: Azithromycin (AZM)
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin (AZM) combined with steroid therapy
Trial: 1627763
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta administered intravenously (i.v.) once a week
Trial: 10738641
Drug: Vincamine test
RxNorm normalized name: vincamine
DrugBank: Vincamine (DB13374)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vincamine test product (60 mg single dose)
Trial: 9462488
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch for 10 weeks as an adjunct to brief counseling
Trial: 29259181
Drug: Omega-3 capsules
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 capsules (2 g/day for 8 weeks)
Trial: 9701531
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg
Trial: 8678098
Drug: Cefepime 2
RxNorm normalized name: cefepime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime 2 g every 12 hours
Trial: 8678098
Drug: Ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 2 g every 8 hours
Trial: 20975611
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor group
Trial: 26040200
Drug: Double antibiotic
RxNorm normalized name: Double Antibiotic
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double antibiotic paste (DAP) 500 mg ml(‐1) + EDTA
Trial: 10468965
Drug: Open GH
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open GH treatment after placebo
Trial: 8862492
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day clomiphene citrate for 3 days
Trial: 31175696
Drug: Hydrogen peroxide
RxNorm normalized name: Hydrogen Peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrogen peroxide 6% solution under occlusion for one hour daily for 6 weeks
Trial: 31175696
Drug: Hydrogen peroxide
RxNorm normalized name: Hydrogen Peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrogen peroxide 3% solution
Trial: 19656577
Drug: Adjunctive aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjunctive aripiprazole (n=373)
Trial: 10220205
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Q10 daily for 3 months
Trial: 7637151
Drug: 25g glucose
RxNorm normalized name: Glucose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 25g glucose infusion in an hour (glucose group)
Trial: 10212537
Drug: Immediate or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate or delayed-immediate implant placement techniques
Trial: 26963600
Drug: Cognitive Behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavior Therapy (CBT)
Trial: 26591679
Drug: Medicine
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medicine
Trial: 18547996
Drug: Erythropoiesis stimulating
RxNorm normalized name: Erythropoiesis stimulating agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoiesis stimulating agents (epoetin) treatment in anemic patients (23 patients)
Trial: 22148098
Drug: 75 mg/day
RxNorm normalized name: Lyllana 0.075 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg/day aspirin
Trial: 2256579
Drug: Low Group
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Group I allergenic house dust (0.66 micrograms/g)
Trial: 31882240
Drug: Tibetan medicated
RxNorm normalized name: ibritumomab tiuxetan
DrugBank: Ibritumomab tiuxetan (DB00078)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tibetan medicated bathing therapy in combination with conventional rehabilitation
Trial: 8534629
Drug: Kabi 2161
RxNorm normalized name: immunoglobulin G, human Injectable Solution [Kabiglobulin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kabi 2161 (600 mg) tablets, 1 four times daily
Trial: 8534629
Drug: Kabi 2161
RxNorm normalized name: immunoglobulin G, human Injectable Solution [Kabiglobulin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kabi 2161 (600 mg) tablets, 2 twice daily
Trial: 24807330
Drug: Indomethacin and
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin and antibiotics
Trial: 10530636
Drug: Desipramine hydrochloride
RxNorm normalized name: Desipramine Hydrochloride
DrugBank: Desipramine (DB01151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desipramine hydrochloride (50 to 150 mg/d)
Trial: 2979286
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg nocte
Trial: 26114240
Drug: Aripiprazole lauroxil
RxNorm normalized name: Aripiprazole lauroxil
DrugBank: Aripiprazole lauroxil (DB14185)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aripiprazole lauroxil 441 mg
Trial: 25765456
Drug: 1 min
RxNorm normalized name: ZINC OXIDE 182.3 mg in 1 mL TOPICAL CREAM [Mini Hueguard 3-in-1 Mineral SPF 30]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 min treatment
Trial: 10716688
Drug: Alpha interferon
RxNorm normalized name: Natural alpha interferon
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha interferon 10 million units three times weekly for 16 weeks (n=69)
Trial: 90215
Drug: Disodium dichloromethylene
RxNorm normalized name: BALSALAZIDE DISODIUM
DrugBank: Balsalazide (DB01014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disodium dichloromethylene diphosphonate 1600 mg/day
Trial: 28914750
Drug: Live-attenuated influenza
RxNorm normalized name: varicella, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live-attenuated influenza vaccine (LAIV)
Trial: 12038039
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei and L. acidophilus strains CERELA
Trial: 1974513
Drug: Chronic administration
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic administration of carvedilol
Trial: 10485531
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received salt solution only
Trial: 1657505
Drug: Simultaneous injection
RxNorm normalized name: Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways
DrugBank: Acazicolcept (DB18410)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous injection of leucine
Trial: 15825072
Drug: Colchicine 0.6
RxNorm normalized name: colchicine 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine 0.6 mg twice per day
Trial: 8431099
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of methylphenidate per day
Trial: 27141626
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia (IVA)
Trial: 8673823
Drug: Ivermectin treatment
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin treatment (multiple doses)
Trial: 28345814
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg once daily plus exenatide 2 mg once weekly
Trial: 29066437
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D 2000 IU (50 μg) daily
Trial: 23850610
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) administration of LIPO-4 vaccine
Trial: 16282845
Drug: Sustained-release bupropion
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release bupropion
Trial: 27793204
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of iron fumarate supplements at one to two daily doses of 100 mg each
Trial: 1684678
Drug: Ketanserin (KS)
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (KS) 40-80 mg daily
Trial: 15477398
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 to 80 mg daily
Trial: 1684678
Drug: Beta-adrenergic blocker
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenergic blocker propranolol (PP)
Trial: 6122752
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of a beta‐blocker
Trial: 1289514
Drug: Verapamil 240
RxNorm normalized name: verapamil 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 240 mg SR
Trial: 7286051
Drug: Chlorthalidone 25
RxNorm normalized name: chlorthalidone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 25 mg
Trial: 3890732
Drug: Single-dose tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose tetracycline (2 g)
Trial: 3890732
Drug: Multi-dose tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multi-dose tetracycline (500 mg four times per day for 10 days)
Trial: 27720506
Drug: 0.2mg oral
RxNorm normalized name: NALDEMEDINE 0.2MG ORAL TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2mg oral clonidine one hour before the operation in addition to standard anesthesia procedure
Trial: 17274708
Drug: Control SEI
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control SEI with dual acid-etched surface without treatment
Trial: 15998659
Drug: FAT infusion
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FAT infusion (long-chain triglyceride emulsion, 2.8 kcal/min)
Trial: 10656432
Drug: Melphalan 40
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Melphalan 40 mg/m2 (n = 6)
Trial: 1993621
Drug: Prolonged treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged treatment elapsed days (14 days beyond the protocol prescription)
Trial: 9828914
Drug: PD-GHRH test
RxNorm normalized name: Poly Hist PD
DrugBank: Thonzylamine (DB11235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PD-GHRH test with HC (80 mg/day for 1 day)
Trial: 6988173
Drug: Oral clenbuterol
RxNorm normalized name: clenbuterol
DrugBank: Clenbuterol (DB01407)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clenbuterol at 20 to 30 micrograms 3-times daily
Trial: 10333820
Drug: Simethicone alone
RxNorm normalized name: Simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simethicone alone (125 mg)
Trial: 6358654
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (CyA) with low-dose steroids
Trial: 31400624
Drug: Adjunctive riluzole
RxNorm normalized name: Riluzole
DrugBank: Riluzole (DB00740)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive riluzole
Trial: 2566222
Drug: UVB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVB treatment
Trial: 17263737
Drug: Intranasal clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal clonidine
Trial: 18652321
Drug: Routine western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine western medicine without acupuncture (Control)
Trial: 8607306
Drug: Epidural group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural group (15 ml of bupivacaine 0.75% via thoracic epidural route)
Trial: 8607306
Drug: Papaveretum group
RxNorm normalized name: papaveretum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Papaveretum group (20‐30 mg of papaveretum i.v.)
Trial: 12741933
Drug: Control site
RxNorm normalized name: SOLO SITE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control site (1 mL saline without dexamethasone)
Trial: 12741933
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg dexamethasone in 1 mL saline through one subcutaneous site (test site)
Trial: 9100588
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose L (0.2 mg/kg) in fasted obese
Trial: 24030130
Drug: TEAM intervention
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TEAM intervention (6-month intervention with scheduled visits, Brief Medication Questionnaires, and toolkits)
Trial: 28645960
Drug: Physiotherapy (PT)
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiotherapy (PT) group received seven PT sessions (one preoperative and six postoperative) incorporating education, manual therapy, and a progressive rehabilitation programme of home, aquatic, and gym exercises.
Trial: 30590587
Drug: Fasting insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fasting insulin
Trial: 7537110
Drug: Interleukin-6 (IL-6)
RxNorm normalized name: autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6) (also termed ssCART-19 cells)
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-6 (IL-6) administered before chemotherapy.
Trial: 7537110
Drug: Interleukin-6 (IL-6)
RxNorm normalized name: autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6) (also termed ssCART-19 cells)
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-6 (IL-6) administered during chemotherapy.
Trial: 7574752
Drug: Intraperitoneal cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal cisplatin (CDDP) chemotherapy, 100 mg of CDDP and 300 ml of saline administered intraperitoneally just after operation for curatively resected patients; same doses for patients with ascites after removal of fluid.
Trial: 340327
Drug: Intensive regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive regimen of Al‐Mg antacid
Trial: 14521760
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (group B)
Trial: 7598243
Drug: ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 4 mg
Trial: 14523485
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C and E (600 mg/day each)
Trial: 28125093
Drug: L-thyroxine (L-T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-thyroxine (L-T4) supplementation at a dose of 5 μg kg-1 day-1
Trial: 26559637
Drug: Vonoprazan 10
RxNorm normalized name: vonoprazan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vonoprazan 10 or 20 mg as maintenance therapy
Trial: 7377745
Drug: Sulfadiazine (SD)
RxNorm normalized name: Sulfadiazine
DrugBank: Sulfadiazine (DB00359)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfadiazine (SD) 250 mg twice daily
Trial: 15221063
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (tailored resection, including microsurgical lesionectomy, lesionectomy plus cortectomy, and hippocampectomy)
Trial: 16428539
Drug: SCH 1
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 1 mg/kg ideal body weight
Trial: 16428539
Drug: SCH 1
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 1 mg/kg total body weight
Trial: 15571211
Drug: Febuxostat 10
RxNorm normalized name: Febuxostat
DrugBank: Febuxostat (DB04854)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Febuxostat 10 mg to 120 mg
Trial: 29121356
Drug: Subconjunctival injection
RxNorm normalized name: STREPTOMYCES GRISEUS 0.05 g in 1 mL SUBCONJUNCTIVAL INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subconjunctival injection of 0.5 mL cefazolin-balanced salt solution (0.3 mL cefazolin and 0.2 mL balanced salt solution)
Trial: 24831447
Drug: Baseline VL
RxNorm normalized name: VL-2397
DrugBank: VL-2397 (DB17796)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline VL >100,000 copies/ml (N = 122)
Trial: 28855078
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment with prasugrel for 12 months)
Trial: 18703188
Drug: Local application
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local application of PRP gel
Trial: 2532868
Drug: Loratadine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine 10 mg
Trial: 17688969
Drug: docetaxel monotherapy
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel monotherapy
Trial: 21224289
Drug: Reconstituted high-density
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reconstituted high-density lipoprotein (rHDL) infusion
Trial: 11812877
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (3 g/day)
Trial: 2192839
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate lozenges (4.5 mg zinc)
Trial: 11196741
Drug: New measles-mumps-rubella
RxNorm normalized name: MEASLES/MUMPS/RUBELLA VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham)
Trial: 15757851
Drug: Levothyroxine (LT4)
RxNorm normalized name: LT4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levothyroxine (LT4) treatment in patients with SH
Trial: 9498653
Drug: Cholesterol supplementation
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol supplementation of 800 mg/day
Trial: 1512807
Drug: Short-term treatment
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term treatment approaches; specific details not available.
Trial: 7733034
Drug: Animal-protein diet
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Animal-protein diet with vitamin B-6 intakes of 0.5, 1.0, 1.5, and 2.0 mg/d
Trial: 2439815
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg
Trial: 23283539
Drug: Ultrasound treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound treatment and exercises
Trial: 31190359
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (1,000 mg omega-3 fatty acids, twice a day for 12 weeks)